Antiphospholipid antibodies and lipoprotein (a) in women with recurrent fetal loss

International Journal of Gynecology and Obstetrics

Volumn 61, Issue 1, 1998, Pages 39-44

  Szczepanski M ^a   Bauer, A ^a   Gardas, A ^a   Duchinski T ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Antiphospholipid antibodies; Lipoprotein (a); Recurrent fetal loss

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPROTEIN A; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FETUS WASTAGE; HUMAN; NORMAL HUMAN; NULLIPARA; PRIORITY JOURNAL; PROGNOSIS; SPONTANEOUS ABORTION;

EID: 0032053704     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(98)00007-1     Document Type: Article

References (15)

1. [1] Schleider MA, Nachman RL, Jaffe EA. A clinical study of the lupus anticoagulant. Blood 1976;48:499-509.
2. [2] Derue G, Englert H, Harris E. Fetal loss in systemic lupus: Association with anticardiolipin antibodies. Br J Obstet Gynaecol 1985;5:207-209.
3. [3] Bick RL, Baker WF Jr. The antiphospholipid and thrombosis syndromes. Med Clin North Am 1994;78:667-684.
4. [4] Edelberg JM, Pizzo SV. Lipoprotein (a): the link between impaired fibrinolysis and atherosclerosis. Fibrinolysis 1991;5:135-143.
5. [5] Yamazaki M, Asakura H, Jokaji H, Saito M, Votani C, Kumabashiri J et al. Plasma levels of lipoprotein (a) are elevated in patients with the antiphospholipid antibody syndrome. Thromb Haemostasis 1994;71:424-427.
6. [6] Gardas A, Bobilewicz D, Antoniak D. Immunoenzymatic assessment of lipoprotein (a) level as an independent atherosclerosis risk factor. (In Polish). Diagn Lab 1996;312:63-70.
7. [7] Creagh MD, Malia RG, Cooper SM, Smith AR, Duncan SLB, Greaves M. Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss. J Clin Pathol 1991;44:45-47.
8. [8] Violi F, Ferro D, Valesini G et al. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis. Br Med J 1990; 300:1099-1102.
9. [9] Kiprov DD, Nachtigall RD, Weaver RC, Jacobson A, Main EK, Garovoy MR. The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. Am J Reprod Immunol 1996;36:228-234.
10. [10] Balasch J, Creus M, Fabregues F, Reverter JC, Carmona F, Tassies D et al. Antiphospholipid antibodies and human reproductive failure. Hum Reprod 1996;11:2310-2315.
11. [11] Yetman DL, Kutteh WH. Antiphospholipid antibody panels and recurrent pregnancy loss: Prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996;66:540-546.
12. [12] Carreras LO, Machin SJ, Deman R et al. Arterial thrombosis, intiauterine death, and lupus anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981;1:242-246.
13. [13] Freyssinet JM, Cazenave JP. Lupus-like anticoagulants modulation of the protein C pathway and thrombosis. Thromb Haemostasis 1987;58:679-681.
14. [14] Triplett DA. Antiphospholipid and thrombosis. Arch Pathol Lab Med 1993;117:78-88.
15. [15] Kwaan HC, Samama MM, Nguyen G. Fibrinolytic system. In: Kwaan HC, Samama MM, editors. Clinical thrombosis. Boca Raton: CRC Press, 1990:23-31.